New flavored drink helps cancer patients keep weight on during treatment

NCT ID NCT06902402

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested three flavors of Supportan® drink (Tropical Fruits, Cappuccino, and Pineapple-Coconut) in 123 cancer patients undergoing chemotherapy, radiotherapy, immunotherapy, or targeted therapy. Patients drank two bottles daily for four weeks alongside their normal diet. The main goal was to see if the drink helped maintain or increase body weight and reduce inflammation. The trial is complete and focused on safety and short-term nutritional support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Supportan® drink (oral nutritional supplement)
What this could lead to
If successful, this could provide a well-tolerated way to help cancer patients maintain weight and meet nutritional needs during treatment.
What could go wrong
This is a small, completed trial focused on short-term weight change and safety, not on curing cancer or improving survival. Results may not apply to all cancer types or longer treatment periods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Keelung Chang Gung Memorial Hospital-Lover's lake branch

    Keelung, Taiwan, 204201, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.